U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
LESABELIMAB
INN  
Official Name English
lesabelimab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL LDP .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LDP .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
FDA UNII
R8ZW84Q6SU
Created by admin on Sat Dec 16 18:09:12 GMT 2023 , Edited by admin on Sat Dec 16 18:09:12 GMT 2023
PRIMARY
INN
11914
Created by admin on Sat Dec 16 18:09:12 GMT 2023 , Edited by admin on Sat Dec 16 18:09:12 GMT 2023
PRIMARY
CAS
2475402-56-1
Created by admin on Sat Dec 16 18:09:12 GMT 2023 , Edited by admin on Sat Dec 16 18:09:12 GMT 2023
PRIMARY
SUBSTANCE RECORD
LESABELIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966